About Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Armata Pharmaceuticals is a biotechnology company focused on developing innovative therapies to treat infectious diseases, particularly those caused by antibiotic-resistant bacteria. The company is leveraging its proprietary technology to create bacteriophage-based treatments, which harness naturally occurring viruses that infect and destroy bacteria. By advancing its clinical pipeline, Armata aims to address the growing public health crisis posed by antibiotic resistance and improve patient outcomes through targeted, effective solutions against complex bacterial infections. Read More
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.
